Replies to post #66157 on Savvy Trades and Investments

[Knowledge is King]

re PGNT($2.45) and ESCC($.63): right on both counts, gil



PGNT reported Q3 EPS of $.17 vs $.14 on a 47% jump in revenues to $30.8M. Nine-month EPS is now $.33 (vs $.09).


ESCC reported a Q3 loss of $.07 vs EPS of $.19. Revenues plunged 53% to $5.7M. The stock looks fairly-priced, at best, here...trading at book value. A bright spot is their cash position, currently $.53/share.


Overall, PGNT shares remain a buy in my view. As for ESCC, I've clearly overstayed the party here. Still can't fathom what the billionaire (Peter R. Kellogg) was seeing in this deal when he was buying stock by the fistful a year-and-a-half ago...